Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
Dirk Arnold, C. S. Fuchs, J. Tabernero, A. Ohtsu, A. X. Zhu, E. B. Garon, J. R. Mackey, L. Paz-Ares, A. D. Baron, T. Okusaka, T. Yoshino, H. H. Yoon, M. Das, D. Ferry, Y. Zhang, Y. Lin, P. Binder, A. Sashegyi, I. Chau
Dive into the research topics of 'Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab'. Together they form a unique fingerprint.